FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

14997711000001102: Ranolazine 500mg modified-release tablets 60 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
52554001000001114 Ranolazine 500mg modified-release tablets 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
52554101000001110 Ranolazine 500mg modified-release tablets 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


4 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranolazine 500mg modified-release tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet Is pack of Ranolazine 500mg modified-release tablets false Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet Has active ingredient Ranolazine false Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet Has VMP Ranolazine 500mg modified-release tablets true Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet Has specific active ingredient Ranolazine true Inferred relationship Existential restriction modifier
Ranolazine 500mg modified-release tablets 60 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ranexa 500mg modified-release tablets (Ethigen Ltd) 60 tablet Is a True Ranolazine 500mg modified-release tablets 60 tablet Inferred relationship Existential restriction modifier
Ranexa 500mg modified-release tablets (DE Pharmaceuticals) 60 tablet Is a True Ranolazine 500mg modified-release tablets 60 tablet Inferred relationship Existential restriction modifier
Ranexa 500mg modified-release tablets (A Menarini Pharma UK S.R.L.) 60 tablet 6 x 10 tablets Is a True Ranolazine 500mg modified-release tablets 60 tablet Inferred relationship Existential restriction modifier
Ranexa 500mg modified-release tablets (Waymade Healthcare Plc) 60 tablet Is a True Ranolazine 500mg modified-release tablets 60 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start